Citation

Verboon LN, Patel HC, Greenhalgh AD. Front. Immunol. 2021; 12: e620698.

Copyright

(Copyright © 2021, Frontiers Research Foundation)

DOI

10.3389/fimmu.2021.620698

PMID

33679762

Abstract

Mild traumatic brain injury (mild TBI), often referred to as concussion, is the most common form of TBI and affects millions of people each year. A history of mild TBI increases the risk of developing emotional and neurocognitive disorders later in life that can impact on day to day living. These include anxiety and depression, as well as neurodegenerative conditions such as chronic traumatic encephalopathy (CTE) and Alzheimer's disease (AD). Actions of brain resident or peripherally recruited immune cells are proposed to be key regulators across these diseases and mood disorders. Here, we will assess the impact of mild TBI on brain and patient health, and evaluate the recent evidence for immune cell involvement in its pathogenesis.

Language: en

Keywords

concussion; microglia; mild TBI; inflammation; neurodegenenerative diseases; neuroimmunology